Eli Lilly introduces 7.5 mg and 10 mg Zepbound vials for $499, expands self-pay options, and lowers prices on 2.5 mg and 5 mg doses for obesity treatment.

The company pledged to soon make its highest marketed Zepbound strengths, the drug's 12.5 mg and 15 mg doses, available in single-dose vials for $499 a month through its LillyDirect self-pay ...

Eli Lilly responded to the high demand for tirzepatide (Zepbound) by announcing yesterday that 2.5 mg and 5 mg single-dose vials are now available for self-pay for patients with an on-label ...

Eli Lilly (LLY) on Tuesday launched higher doses of Zepbound, or tirzepatide, in single-dose vials and reduced the prices of two smaller doses of the weight-loss drug for self-pay patients. The ...

(RTTNews) - Eli Lilly and Company (LLY) has launched 7.5 mg and 10 mg Zepbound single-dose vials for $499 under the Zepbound Self Pay Journey Program, making the obesity medication more affordable ...

Self-pay patients with obesity now have additional Zepbound vial options, including 2.5 mg, 5 mg, 7.5 mg and 10 mg doses. In addition to expanding the doses available, Lilly is taking steps to ...

The move significantly expands the supply of Zepbound in response to high demand and offers a more affordable option for those who self-pay. The vials are priced a minimum of 50% lower than the ...

Patients with obesity who choose to self pay will soon be able to access the complete range of Zepbound single-dose vials, including 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg. Patients on ...

Self-pay patients with obesity now have additional Zepbound vial options, including 2.5 mg, 5 mg, 7.5 mg and 10 mg doses. In addition to expanding the doses available, Lilly is taking steps to ...

With the addition of 12.5 mg and 15 mg vials, all approved doses of Zepbound will be available in single-dose vials for $499/month or less, regardless of insurance status, under Zepbound Self Pay ...

New 7.5 mg and 10 mg Zepbound single-dose vials now available for $499 per month via Zepbound Self Pay Journey Program Lilly launches additional Zepbound vial doses and offers new savings for self ...